Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/28/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Richard E. Chipkin

Wrong Dr. Richard E. Chipkin?

President and Chief Executive Off...

Psyadon Pharmaceuticals , Inc.
20451 Seneca Meadows Parkway
Germantown, Maryland 20876
United States

Company Description: Psyadon Pharmaceuticals is dedicated to the discovery and development of new treatments for the serious psychiatric and neurological diseases. Ecopipam, our first...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • undergraduate degree , Pharmacology
    State University of New York at Albany
  • Ph.D. , Pharmacology
    Medical College of Virginia
58 Total References
Web References
Paragon Bioservices CEO Elected to the MdBio Division Board of Directors
www.paragonbioservices.com, 28 April 2014 [cached]
• Richard E. Chipkin, Ph.D., President and CEO, Psyadon Pharmaceuticals
Psyadon Pharmaceuticals Home Page
www.psyadonrx.com, 25 Jan 2014 [cached]
Dr. Richard E. Chipkin, PhD, President and CEO
Dr. Chipkin has more than 20 years experience at both biotech and big pharmaceutical companies. Most recently, he was President and CEO of Psychiatric Genomics. While there, he raised two rounds of venture capital financing, re-organized the company, and negotiated multiple academic licenses. Prior to that, he worked at Schering-Plough Corporation in the Global Business Development Group, where he was responsible for licensing and acquisition in multiple therapeutic areas. In this capacity, Dr. Chipkin negotiated several multi-million dollar research & development and development/marketing deals, including the license for INTEGRILIN®, currently a $250M/year product. Earlier in his career at Schering-Plough, he held positions in both preclinical and clinical neuropharmacology research. Among his accomplishments in the research arena were the discovery of novel analgesic and antipsychotic drugs, including the identification and human testing of ecopipam -- the world's first selective D1 antagonist. Dr. Chipkin received his undergraduate degree from the State University of New York at Albany and his PhD in Pharmacology from the Medical College of Virginia. He did post-doctoral work at the University of Colorado Medical Center.
About TCM - Board of Directors - Tech Council of Maryland
www.techcouncilmd.com, 22 Jan 2014 [cached]
Richard E. Chipkin, Ph.D. President and Chief Executive Officer Psyadon Pharmaceuticals
Ruxton Pharmaceuticals, Inc.
www.ruxtonrx.com, 22 Oct 2009 [cached]
Richard E. Chipkin, PhD President and C.E.O.
Dr. Chipkin has more than 20 years experience at both biotech and big pharmaceutical companies. Most recently, he was President and CEO of Psychiatric Genomics, a private, venture-backed company. While there, he raised two rounds of venture capital financing, re-organized the company, and negotiated multiple academic licenses.
Prior to that, he worked at Schering-Plough Corporation in the Global Business Development Group, where he was responsible for licensing and acquisition in multiple therapeutic areas. In this capacity, Dr. Chipkin negotiated several multi-million dollar research & development and development/marketing deals, including the license for INTEGRILIN®, currently a $250M/year product. In addition, he was responsible for maintaining all business development relationships with Japanese pharmaceutical companies and concluded a deal with Chugai for a dermatology product. Earlier in his career at Schering-Plough, he held positions in both preclinical and clinical neuropharmacology research. Among his accomplishments in the research arena were the discovery of novel analgesic and antipsychotic drugs, including the identification and human testing of ecopipam -- the world's first selective D1/D5 antagonist.
Dr. Chipkin received his undergraduate degree from the State University of New York at Albany and his PhD in Pharmacology from the Medical College of Virginia. He did post-doctoral work at the University of Colorado Medical Center.
Ruxton Pharmaceuticals, Inc.
www.ruxtonrx.com, 22 Oct 2009 [cached]
Richard E. Chipkin, PhD President and C.E.O., Ruxton Pharmaceuticals, Inc.
Other People with the name "Chipkin":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.